Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial
Source : https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-021-01234-6
Objective This study aimed to assess the efficacy of concurrent magnesium-sodium valproate therapy and compare it with either magnesium or sodium valproate alone in migraine prophylaxis. Materials and methods This randomized single-center double-blind parallel-group controlled clinical trial study was conducted on migraine patients within the age range of 18-65 years.
-
Huma Sheikh, CEO, NY Neurology Medicine, PCApril 19, 2021This is helpful information.